US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2015
3/18/2015 | published by: BMI Research
... sector as pivotal to political stability and we believe that actual spending will yet again exceed the amount budgeted with the availability of vast foreign exchange reserves. This reaffirms our view that Saudi Arabia is ...  |  read more...
USD 1,295
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015
3/18/2015 | published by: BMI Research
... market players, Sri Lanka is burdened by a prevalence of corruption and price controls, while also being reliant on outside aid. Headline Expenditure Projections Pharmaceuticals: LKR75.09bn (USD575mn) in 2014 to LKR82.07bn (USD608mn) in 2015; +9.3% ...  |  read more...
USD 1,295
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015
3/18/2015 | published by: BMI Research
... is a key international player, and will continue to be for the foreseeable future. However, the climate of cost containment, coupled with patent expirations, will lower the overall value of the UK's drug market. Headline ...  |  read more...
USD 1,295
The US Market for Rx to OTC Switches, 7th Edition
2/2/2015 | published by: Kalorama Information
... expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as ...  |  read more...
USD 3,995
Mozambique Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... healthcare sector - which suffers from shortages of health professionals andpoor access to treatment facilities - should begin to show signs of improvement with the help of foreigninvestment. However, previous risks to market growth remain ...  |  read more...
USD 1,295
Poland Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... Over the past fiveyears, Poland's economic outperformance has been vital to maintaining positive growth for the private andpublic healthcare sectors. While Poland's economy may continue to outperform in terms of growth, webelieve that overall healthcare ...  |  read more...
USD 1,295
Canada Pharmaceuticals and Healthcare Report Q2 2015
2/25/2015 | published by: BMI Research
... one of the largest inworld. We believe that drugmakers will continue to realise considerable rewards, as sales of patentedpharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularlyslow penetration ...  |  read more...
USD 1,295
France Pharmaceuticals and Healthcare Report Q2 2015
2/25/2015 | published by: BMI Research
... capita spending levels on medicines. However, several cost-containment measures will continue to exert downward pressure on market growthover a multi-year horizon. On the upside, current macroeconomic trends, including low oil and food prices,should be net ...  |  read more...
USD 1,295
Myanmar Pharmaceuticals and Healthcare Report Q2 2015
2/25/2015 | published by: BMI Research
... the opportunity ofsecuring a first-mover advantage in this frontier market, as well as being a result of rising medicineconsumption. Nonetheless, we highlight that there is significant political uncertainty in Myanmar with theupcoming 2015 elections which ...  |  read more...
USD 1,295
Cameroon Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: BMI Research
... combination of rising consumer spending, global aid funds and Cameroon's government recentcommitment to enhance investment through 2015-2018 in several key areas, including the health sector,will sustain market development. Meanwhile, we expect mobile health innovations to ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: BMI Research
... and expanding counterfeit drug market continue to hinder progress for the Colombian governmentand pharmaceutical market. Headline Expenditure Projections Pharmaceuticals: COP8,643bn (USD4.38bn) in 2014 to COP9,118bn (USD4.3bn) in 2015; +5.5% inlocal currency terms and -2.1% in ...  |  read more...
USD 1,295
New Zealand Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... ageing andexpanding population. However, the conversion of such potential into rewards for multinationals willremain largely dependent upon PHARMAC's budget which, already oversubscribed, is unlikely to receivesignificant extensions to its annual increase over our forecast period. ...  |  read more...
USD 1,295
Bulgaria Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... healthcare financing, we holda more positive view for the long term development of the pharmaceutical & healthcare sector. Headline Expenditure Projections Pharmaceuticals: BGN2.50bn (USD1.71bn) in 2014 to BGN2.41bn (USD1.54bn) in 2015; -3.7% inlocal currency terms ...  |  read more...
USD 1,295
Germany Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... patented medicines. In spiteof this, additional restrictions on reimbursement, tempered by government's desire to preserve an industryintegral to Germany's positive balance of trade and international prestige, will nonetheless constrainrevenues and intensify already fierce competition amongst ...  |  read more...
USD 1,295
Jordan Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... toSyrian refugees in Jordan. The government will have more funds to invest in the development of the publichealthcare sector, which was previously overburdened with refugees, though regional instability willcontinue to weigh on Jordan's attractiveness as ...  |  read more...
USD 1,295
Pharmacies and Drug Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 446110
2/19/2015 | published by: Plunkett Research, Ltd.
... hours of research. Key Findings: Pharmacies and Drug Stores Industry (U.S.) to reach $340 billion by 2021. Pharmacies and Drug Stores Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: ...  |  read more...
USD 1,995
Czech Republic Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: BMI Research
... decline. Indeed, thesechanges will help to provide for the growing demand for innovative drugs among the country's ageingpopulation. The healthcare spending of the Czech population remains superior to that of the less-developedmarkets of Eastern and ...  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: BMI Research
... list of reimbursabledrugs this quarter. Commercial opportunities exist in the Gabonese pharmaceutical market, which isbecoming increasingly attractive to drugmakers due to an improving regulatory environment. Headline Expenditure Forecasts Pharmaceuticals: XAF50.94bn (USD104mn) in 2014 to XAF54.14bn ...  |  read more...
USD 1,295
Pharmaceutical Industry in India – Porter’s Five Forces Strategy Analysis
3/1/2015 | published by: Aruvian's R'search
... being an import dependent industry in the 1950s, the industry has achieved self-sufficiency and gained global recognition as a producer of low cost high quality bulk drugs and formulations. Leading Indian companies have developed infrastructure ...  |  read more...
USD 300
Israel Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: BMI Research
... will be seen as positive by innovative drugmakers. Risks to our outlook include politicaluncertainty and the fiscal deficit, which pose a risk to the government's planned healthcare expenditure. Headline Expenditure Projections Pharmaceuticals: ILS7.51bn (USD2.10bn) in ...  |  read more...
USD 1,295
Pakistan Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: BMI Research
... poormedical infrastructure, low per capita pharmaceutical spending and high levels of counterfeit medicinesprevent the market from realising its full potential. Headline Expenditure Projections Pharmaceuticals: PKR231.2bn (USD2.29bn) in 2014 to PRK254.6bn (USD2.47bn) 2015; +10.1%inlocal currency terms ...  |  read more...
USD 1,295
Hong Kong Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... system. While this couldcreate cost barriers to medicines, we highlight that the strong earning power of the majority of thepopulation as well as a robust private healthcare system will continue to offer strong commercialopportunities for ...  |  read more...
USD 1,295
Japan Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... the government to use costcontainment measures including policies to encourage the uptake of generic drug medicines, posing adownside risk for R&D-based pharmaceutical companies Headline Expenditure Projections Pharmaceuticals: JPY11,239bn (USD107bn) in 2014 to JPY11,490bn (USD96bn) by ...  |  read more...
USD 1,295
Mauritius Pharmaceuticals and Healthcare Report Q1 2015
2/18/2015 | published by: BMI Research
... as an attractive destination for future growth - although the destination stillremains relatively untouched on a local level. Headline Expenditure Projections Pharmaceuticals: MUR6.01bn (USD196mn) in 2013 to MUR6.48bn (USD214mn) in 2014; 7.78% growthin local currency ...  |  read more...
USD 1,295
Peru Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: BMI Research
... while thepharmaceutical and healthcare markets continue to grow, the national economy continues to struggle andits dependence on key exports will hamper overall growth in the short-term. Headline Expenditure Projections Pharmaceuticals: PEN4.7bn (USD1.65bn) in 2014 to ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10